Kaman

Paromomycin Sulfate, the active ingredient in Kaman, is an aminoglycoside antibiotic presented as an oral formulation for systemic use. It is employed to treat infections caused by protozoa such as Entamoeba histolytica, Giardia lamblia, Cryptosporidium species, and certain forms of Leishmania, primarily in adult patients. It is indicated for both acute and chronic protozoal infections and is used under medical supervision.

GNH USA supplies Kaman as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows EU GMP standards and provides batch‑tested product for global distribution.

Paromomycin Sulfate is used to treat protozoal infections affecting the gastrointestinal tract and systemic disease. - Amoebiasis: eradicates Entamoeba histolytica and resolves dysentery symptoms. - Giardiasis: eliminates Giardia lamblia, reducing diarrhea and malabsorption. - Cryptosporidiosis: clears Cryptosporidium infection, improving stool consistency. - Visceral leishmaniasis (oral use): contributes to parasite clearance in systemic leishmaniasis.

Paromomycin Sulfate may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset. - Vomiting: occasional emesis. - Diarrhea: loose stools. - Abdominal pain: cramping discomfort.

Serious or Rare Side Effects: - Ototoxicity: hearing loss or ringing. - Nephrotoxicity: impaired kidney function. - Severe allergic reaction: rash, swelling, anaphylaxis.

When prescribing Paromomycin Sulfate, clinicians should observe several safety considerations. - Renal function: assess kidney status before initiating therapy. - Hearing assessment: monitor for signs of ototoxicity, especially in prolonged use. - Concomitant nephrotoxic drugs: avoid or adjust dosing when used with other renal‑toxic agents. - Pregnancy and lactation: use only if potential benefit outweighs risk, due to limited data. - Pediatric use: dosage must be determined by a qualified healthcare professional. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Paromomycin Sulfate can interact with other medicines, influencing efficacy or toxicity.

Major Interactions (Avoid): - Loop diuretics: increase risk of nephrotoxicity. - Aminoglycoside antibiotics: additive ototoxic and nephrotoxic effects. - Muscle relaxants (e.g., pancuronium): potentiate neuromuscular blockade.

Moderate Interactions (Monitor Closely): - NSAIDs: may enhance renal impairment. - Vancomycin: combined use may increase nephrotoxic potential. - Antacids containing magnesium or aluminum: may reduce oral absorption.